Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
REGENXBIO Inc. (NASDAQ: RGNX)
RGNX Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
16.50%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
353.40%
RGNX Stock Analysis
RGNX
PE Ratio:
RGNX
PEG Ratio:
Not Available
RGNX
Forward EPS Growth (12 month):
0.00%
RGNX
PS Ratio:
3.9
RGNX
PSG Ratio:
0.2
RGNX
Forward Revenue Growth (12 month):
20.40%
RGNX Articles
No data was found